KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Equity Average: 2010-2025

Historic Equity Average for Idexx Laboratories (IDXX) over the last 15 years, with Sep 2025 value amounting to $1.5 billion.

  • Idexx Laboratories' Equity Average fell 5.57% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 5.57%. This contributed to the annual value of $1.5 billion for FY2024, which is 47.13% up from last year.
  • Per Idexx Laboratories' latest filing, its Equity Average stood at $1.5 billion for Q3 2025, which was up 3.89% from $1.5 billion recorded in Q2 2025.
  • Idexx Laboratories' Equity Average's 5-year high stood at $1.6 billion during Q4 2024, with a 5-year trough of $466.5 million in Q3 2022.
  • In the last 3 years, Idexx Laboratories' Equity Average had a median value of $1.5 billion in 2025 and averaged $1.4 billion.
  • Per our database at Business Quant, Idexx Laboratories' Equity Average soared by 367.41% in 2021 and then plummeted by 37.95% in 2022.
  • Idexx Laboratories' Equity Average (Quarterly) stood at $722.7 million in 2021, then fell by 24.96% to $542.4 million in 2022, then soared by 156.46% to $1.4 billion in 2023, then rose by 15.51% to $1.6 billion in 2024, then declined by 5.57% to $1.5 billion in 2025.
  • Its Equity Average was $1.5 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.5 billion in Q1 2025.